This is Science Today. A new study has found a majority
of doctors are not prescribing ACE inhibitors, a
popular heart failure drug, in high enough doses
for effective treatment. Dr. Andrew Michaels of
the University of California, San Francisco, says
certain high-risk patients, such as those who have
had angioplasty or a bypass, are often not even
given ACE inhibitors.
Michaels: Part of that potentially could
be that some physicians may feel that after a patient
is revascularized with either a bypass or an angioplasty,
their benefit from ACE inhibitors might be a little
less, although no clinical trial would support that
Narrator: And no clinical trial could support the idea that higher doses of ACE inhibitors are unsafe. So Michaels says these drugs should be used more aggressively, especially in those patients with congestive heart failure.
Michaels: Those patients are at really high risk of having another heart attack or dying within the next year. And if those patients are discharged on the ACE inhibitor, those rates of complications go down dramatically.
Narrator: For Science Today, I'm Larissa